全文获取类型
收费全文 | 25664篇 |
免费 | 2593篇 |
国内免费 | 106篇 |
专业分类
耳鼻咽喉 | 252篇 |
儿科学 | 964篇 |
妇产科学 | 678篇 |
基础医学 | 3673篇 |
口腔科学 | 419篇 |
临床医学 | 3658篇 |
内科学 | 5456篇 |
皮肤病学 | 639篇 |
神经病学 | 2595篇 |
特种医学 | 589篇 |
外国民族医学 | 4篇 |
外科学 | 2666篇 |
综合类 | 218篇 |
一般理论 | 6篇 |
预防医学 | 2535篇 |
眼科学 | 317篇 |
药学 | 1663篇 |
中国医学 | 20篇 |
肿瘤学 | 2011篇 |
出版年
2023年 | 247篇 |
2022年 | 389篇 |
2021年 | 777篇 |
2020年 | 624篇 |
2019年 | 932篇 |
2018年 | 1040篇 |
2017年 | 807篇 |
2016年 | 870篇 |
2015年 | 916篇 |
2014年 | 1100篇 |
2013年 | 1520篇 |
2012年 | 1917篇 |
2011年 | 1803篇 |
2010年 | 1159篇 |
2009年 | 1036篇 |
2008年 | 1546篇 |
2007年 | 1550篇 |
2006年 | 1429篇 |
2005年 | 1345篇 |
2004年 | 1269篇 |
2003年 | 1132篇 |
2002年 | 1047篇 |
2001年 | 261篇 |
2000年 | 241篇 |
1999年 | 271篇 |
1998年 | 268篇 |
1997年 | 205篇 |
1996年 | 169篇 |
1995年 | 169篇 |
1994年 | 140篇 |
1993年 | 123篇 |
1992年 | 123篇 |
1991年 | 126篇 |
1990年 | 125篇 |
1989年 | 112篇 |
1988年 | 113篇 |
1987年 | 83篇 |
1986年 | 96篇 |
1985年 | 81篇 |
1984年 | 88篇 |
1983年 | 92篇 |
1982年 | 86篇 |
1981年 | 88篇 |
1980年 | 49篇 |
1979年 | 50篇 |
1978年 | 55篇 |
1977年 | 54篇 |
1976年 | 67篇 |
1975年 | 45篇 |
1974年 | 52篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Malena Mielke Lea Marie Reisch Alexandra Mehlmann Sebastian Schindler Christian G. Bien Johanna Kissler 《Human brain mapping》2022,43(2):787
Human vision prioritizes emotional stimuli. This is reflected in stronger electrocortical activation in response to emotional than neutral stimuli, measurable on the surface of the head. Feedback projections from brain structures deep within the medial temporal lobes (mTLs), in particular the amygdala, are thought to give rise to this phenomenon, although causal evidence is rare. Given the many pathways involved in visual processing, the influence of mTL structures could be restricted to specific time windows. Therefore, we delineate the temporal dynamics of the impact of right mTL structures on affective picture processing, investigating event‐related potentials (ERPs) in 19 patients (10 female) with right mTL resections and 19 individually matched healthy participants, while they viewed negative and neutral scenes. Groups differed significantly at early‐ and mid‐latency processing stages. Patients with right mTL resection, unlike controls, showed no (P1: 90–140 ms) or marginal (N1: 170–220 ms) emotion modulation. At mid‐latency (early posterior negativity: 220–370 ms), emotion modulation over the ipsi‐resectional right hemisphere was smaller in patients than in controls, but groups did not differ over the left hemisphere. During late parietal positivities (400–650 ms and 650–900 ms), both groups had similar emotion modulation. Our results demonstrate that right mTL structures attenuate particularly early processing of affectively negative scenes. This is theoretically consistent with an initial amygdala‐dependent feedforward sweep in visual emotion processing whose absence is successively compensated. Findings specify the impact of right mTL structures on emotional picture processing and highlight the value of time‐resolved measures in affective neuroscience.We have compared event‐related potential correlates of affective picture processing in 19 patients with right temporal lobe resections including the amygdala and individually matched healthy controls. Our results show that particularly early processing stages (P1, ipsi‐resectional N1 and early posterior negativity) are impaired by the resections, whereas late positivities are largely intact. These findings constrain theories on the role of medial temporal lobe structures in visual affective stimulus processing. 相似文献
993.
Fiene Marie Kuijper Uma V. Mahajan Seul Ku Daniel A.N. Barbosa Sheila M. Alessi Sherman C. Stein Kyle M. Kampman Brandon S. Bentzley Casey H. Halpern 《Neuromodulation》2022,25(2):253-262
ObjectivesCocaine is the second most frequently used illicit drug worldwide (after cannabis), and cocaine use disorder (CUD)-related deaths increased globally by 80% from 1990 to 2013. There is yet to be a regulatory-approved treatment. Emerging preclinical evidence indicates that deep brain stimulation (DBS) of the nucleus accumbens may be a therapeutic option. Prior to expanding the costly investigation of DBS for treatment of CUD, it is important to ensure societal cost-effectiveness.AimsWe conducted a threshold and cost-effectiveness analysis to determine the success rate at which DBS would be equivalent to contingency management (CM), recently identified as the most efficacious therapy for treatments of CUDs.Materials and MethodsQuality of life, efficacy, and safety parameters for CM were obtained from previous literature. Costs were calculated from a societal perspective. Our model predicted the utility benefit based on quality-adjusted life-years (QALYs) and incremental-cost-effectiveness ratio resulting from two treatments on a one-, two-, and five-year timeline.ResultsOn a one-year timeline, DBS would need to impart a success rate (ie, cocaine free) of 70% for it to yield the same utility benefit (0.492 QALYs per year) as CM. At no success rate would DBS be more cost-effective (incremental-cost-effectiveness ratio <$50,000) than CM during the first year. Nevertheless, as DBS costs are front loaded, DBS would need to achieve success rates of 74% and 51% for its cost-effectiveness to exceed that of CM over a two- and five-year period, respectively.ConclusionsWe find DBS would not be cost-effective in the short term (one year) but may be cost-effective in longer timelines. Since DBS holds promise to potentially be a cost-effective treatment for CUDs, future randomized controlled trials should be performed to assess its efficacy. 相似文献
994.
Cost‐effectiveness analysis of epilepsy surgery in a controlled cohort of adult patients with intractable partial epilepsy: A 5‐year follow‐up study 下载免费PDF全文
Marie‐Christine Picot Audrey Jaussent Dorine Neveu Philippe Kahane Arielle Crespel Philippe Gelisse Edouard Hirsch Philippe Derambure Sophie Dupont Elizabeth Landré Francine Chassoux Luc Valton Jean‐Pierre Vignal Cécile Marchal Catherine Lamy Franck Semah Arnaud Biraben Alexis Arzimanoglou Jérôme Petit Pierre Thomas Valérie Macioce Pierre Dujols Philippe Ryvlin 《Epilepsia》2016,57(10):1669-1679
995.
996.
Consumption profile and factors associated with the ingestion of beer and distilled beverages among elderly Brazilians: Gender differences 下载免费PDF全文
997.
Qualitative study of peer workers within the ‘Partners in Recovery’ programme in regional Australia 下载免费PDF全文
998.
Jaccard A Gachard N Marin B Rogez S Audrain M Suarez F Tilly H Morschhauser F Thieblemont C Ysebaert L Devidas A Petit B de Leval L Gaulard P Feuillard J Bordessoule D Hermine O;GELA GOELAMS Intergroup 《Blood》2011,117(6):1834-1839
Extranodal NK/T-cell lymphoma, nasal type, is a rare and highly aggressive disease with a grim prognosis. No therapeutic strategy is currently identified in relapsing patients. We report the results of a French prospective phase II trial of an L-asparaginase-containing regimen in 19 patients with relapsed or refractory disease treated in 13 centers. Eleven patients were in relapse and 8 patients were refractory to their first line of treatment. L-Asparaginase-based treatment yielded objective responses in 14 of the 18 evaluable patients after 3 cycles. Eleven patients entered complete remission (61%), and only 4 of them relapsed. The median overall survival time was 1 year, with a median response duration of 12 months. The main adverse events were hepatitis, cytopenia, and allergy. The absence of antiasparaginase antibodies and the disappearance of Epstein-Barr virus serum DNA were significantly associated with a better outcome. These data confirm the excellent activity of L-asparaginase-containing regimens in extranodal NK/T-cell lymphoma. L-Asparaginase-based treatment should thus be considered for salvage therapy, especially in patients with disseminated disease. First-line L-asparaginase combination therapy for extranodal NK/T-cell lymphoma warrants evaluation in prospective trials. This trial is registered at www.clinicaltrials.gov as #NCT00283985. 相似文献
999.
1000.
Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7α-hydroxy dehydroepiandrosterone and 7α-hydroxy pregnenolone 下载免费PDF全文
Ken A. Rose Genevieve Stapleton Karin Dott Marie Paule Kieny Ruth Best Margrit Schwarz David W. Russell Ingemar Bjrkhem Jonathan Seckl Richard Lathe 《Proceedings of the National Academy of Sciences of the United States of America》1997,94(10):4925-4930
Steroids produced locally in brain (neurosteroids), including dehydroepiandrosterone (DHEA), influence cognition and behavior. We previously described a novel cytochrome P450, Cyp7b, strongly expressed in rat and mouse brain, particularly in hippocampus. Cyp7b is most similar to steroidogenic P450s and potentially could play a role in neurosteroid metabolism. To examine the catalytic activity of the enzyme mouse Cyp7b cDNA was introduced into a vaccinia virus vector. Extracts from cells infected with the recombinant showed NADPH-dependent conversion of DHEA (Km, 13.6 μM) and pregnenolone (Km, 4.0 μM) to slower migrating forms on thin layer chromatography. The expressed enzyme was less active against 25-hydroxycholesterol, 17β-estradiol and 5α-androstane-3β,17β-diol, with low to undetectable activity against progesterone, corticosterone, and testosterone. On gas chromatography and mass spectrometry of the Cyp7b metabolite of DHEA the retention time and fragmentation patterns were identical to those obtained with authentic 7α-hydroxy DHEA. The reaction product also comigrated on thin layer chromatography with 7α-hydroxy DHEA but not with 7β-hydroxy DHEA; when [7α-3H]pregnenolone was incubated with Cyp7b extracts the extent of release of radioactivity into the medium suggested that hydroxylation was preferentially at the 7α position. Brain extracts also efficiently liberated tritium from [7α-3H]pregnenolone and converted DHEA to a product with a chromatographic mobility indistinguishable from 7α-hydroxy DHEA. We conclude that Cyp7b is a 7α-hydroxylase participating in the synthesis, in brain, of neurosteroids 7α-hydroxy DHEA, and 7α-hydroxy pregnenolone. 相似文献